Drug Topics

OCTOBER 7, 2024

A roundtable session discussed the real-world implications of applying DIR fees at the point of sale rather than through retroactive clawback.

200

200

STAT

OCTOBER 7, 2024

LONDON — A pair of scientists who discovered a type of RNA molecule that helps control the activity of genes — allowing our cells to perform all their myriad of functions in different tissues throughout the body — won the 2024 Nobel Prize in medicine or physiology on Monday. The award went to Victor Ambros and Gary Ruvkun for their research into microRNA, which the Nobel committee described as a “groundbreaking discovery [that] revealed a completely new principle of g

145

145

Drug Topics

OCTOBER 7, 2024

Although there has recently been an effort to improve pediatric pain treatment, it is still often underestimated and not adequately managed.

187

187

STAT

OCTOBER 7, 2024

Over the past 150 years, humanity has unleashed unimaginable energy by splitting atoms and developed machines that allow us to soar through the skies. But arguably, our species’ most profound change has been far more basic: People generally live a lot longer than they used to. This trend has now substantially slowed in wealthier nations, which appear to be nearing a limit in life expectancy improvements from modern medicine, according to a new study.

144

144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

OCTOBER 7, 2024

Eligible patients can receive a 30-day supply of covered drugs and medical supplies that can be renewed every 30 days for as long as an Emergency Prescription Assistance Program (EPAP) is active.

144

144

STAT

OCTOBER 7, 2024

The conversation about the mental health crisis is loud, but at a standstill. Stuck on repeat around the challenges of accessing existing treatments, the situation can appear increasingly hopeless.  I see another future — one far more positive and exciting. We are on the cusp of a revolution in mental health science. In five years’ time, the mental health treatment landscape will look radically different.

144

144

STAT

OCTOBER 7, 2024

An organization scouring thousands of existing drugs to see if any can cure hard-to-treat diseases has a powerful new ally: Janet Woodcock, who for decades was one of the most influential figures at the Food and Drug Administration. The group, Every Cure, is led by physician David Fajgenbaum, who has told his own story again and again: When he was a young medical student, he came down with a rare disease that turned his athletic, football-honed body bloated and weak and nearly killed him not onc

FDA 141

FDA 141

Pharmacy Times

OCTOBER 7, 2024

Setrusumab could offer a rapid and clinically meaningful decrease in fracture rate in individuals with osteogenesis imperfecta.

FDA 139

FDA 139

STAT

OCTOBER 7, 2024

Gary Ruvkun is used to getting awards — but for him, the Nobel Prize is in a class of its own. “I’ve won 10 to 20 awards in the last 20 years, but never had a press conference with cameras and nothing like this,” Ruvkun, who along with Victor Ambros received the 2024 award in medicine or physiology on Monday, said at a press conference at Massachusetts General Hospital.

Medical Schools 137

Medical Schools Hospitals 137

Fierce Pharma

OCTOBER 7, 2024

After winning a first-in-class nod for its two-drug inhaler Airsupra l | After winning a first-in-class nod for its two-drug inhaler Airsupra last January, AstraZeneca is bolstering the rescue treatment’s clinical package with new data showing it can cut the risk of asthma exacerbations regardless of patients’ disease severity.

Packaging 136

Packaging 136

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 7, 2024

From the earliest days of the H5N1 bird flu outbreak in dairy cattle, experts watching the evolving situation have worried about California.  The Golden State has the country’s largest concentration of dairy farms, roughly 1,100 herds. The concern has been if the virus got into California, the prospects for spread would be huge and containment a challenge.

137

137

Fierce Healthcare

OCTOBER 7, 2024

The healthcare industry is making the push toward greater adoption of value-based care, yet it's not a secret that progress has been slow-moving. | The healthcare industry is making the push toward greater adoption of value-based care, yet it's not a secret that progress has been slow-moving. With that backdrop, UnitedHealth Group has released its latest "A Path Forward" report, which is a biennial look at progress in the shift to value.

130

130

STAT

OCTOBER 7, 2024

From antibody-drug conjugates to immuno-oncology checkpoint inhibitors, China is the world’s most closely watched rising biotechnology power. The growth of China’s industry can be attributed to a number of factors, including beneficial state policies and fresh injections of funding. There has also been bold regulatory reform. Since 2015, the country’s National Medical Products Administration has issued one milestone regulation after another, greatly accelerating the process

Vaccines 128

Vaccines 128

Fierce Pharma

OCTOBER 7, 2024

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their generic to Novo Nordisk's wildly popular Type 2 diabetes drug Ozempic. | Mylan Pharmaceuticals and Novo Nordisk have reached a confidential settlement in a patent lawsuit tied to generic Ozempic, also known as semaglutide, India’s Natco Pharma said.

124

124

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

OCTOBER 7, 2024

Treosulfan showed superior benefits to busulfan as a conditioning regimen before allogenic hematopoietic stem cell transplantation (allo-HSCT).

123

123

Pharmaceutical Technology

OCTOBER 7, 2024

The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with relapsed or refractory T-cell leukaemia.

121

121

Pharmacy Times

OCTOBER 7, 2024

Teresa Messick, PharmD discusses how meeting patients “where they are” and supporting them holistically through medication and beyond is the most rewarding part of the profession.

123

123

pharmaphorum

OCTOBER 7, 2024

The recent Mpox outbreak highlights the urgent need for new approaches to therapeutic antibody research. Discover how the World Health Organization (WHO) and CDC are responding to this public health crisis.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

OCTOBER 7, 2024

At the 2024 World Conference on Lung Cancer, Benjamin Besse, MD, PhD, discussed the findings of the phase 3 CARMEN-LCO3 trial, which led to the discontinuation of the study drug by the manufacturer.

123

123

Fierce Healthcare

OCTOBER 7, 2024

Tucked within bipartisan telehealth legislation that passed out of a House committee in September is the Prevent Diabetes Act, a bill that would expand Medicare coverage for virtual diabetes preven | Companies like Omada Health and Noom are urging Congress to pass the Prevent Diabetes Act to expand access to virtual diabetes prevention for Medicare beneficiaries.

116

116

Pharmacy Times

OCTOBER 7, 2024

Zodasiran is an RNA interference therapy targeting the ANGPTL3 loss-of-function mutation.

123

123

STAT

OCTOBER 7, 2024

The biotech company Scholar Rock reported Monday that its experimental medicine improved motor function in patients with a muscle-wasting disease called spinal muscular atrophy, paving the way for the likely approval of the drug. In a year-long Phase 3 trial, the company tested the drug, called apitegromab, on top of existing treatments for the disease.

116

116

pharmaphorum

OCTOBER 7, 2024

Learn how accessible technology support can help in managing the UK's ADHD medication supply crisis within the NHS, and improve outcomes for patients.

115

115

Drug Topics

OCTOBER 7, 2024

Researchers analyzed the impact of real-time prescription benefits on prescribing patterns by evaluating subsequent fill rates and copay costs.

112

112

pharmaphorum

OCTOBER 7, 2024

Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA

111

111

Drug Topics

OCTOBER 7, 2024

See what’s trending in pharmacy with a preview of the Total Pharmacy October issue.

112

112

pharmaphorum

OCTOBER 7, 2024

Stay updated on the latest advancements in early detection and innovative therapies targeting tau pathology in Alzheimer’s disease. Learn more about the cutting-edge research and treatments available.

110

110

Drug Topics

OCTOBER 7, 2024

The company will be presenting the full BATURA study data as a late-breaker oral presentation at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting.

112

112

pharmaphorum

OCTOBER 7, 2024

UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific researchers, taking on some of the responsibility held by GPs. The minister told the Royal College of General Practitioners (RCGP) annual conference that, while many UK patients have given their consent for their data to be shared with studies run by the likes of the UK Biobank, Genomics England, and Our Future Health, they "still see, far too often, that this data is not shared

110

110

Pharmaceutical Technology

OCTOBER 7, 2024

The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of finasteride.

105

105

pharmaphorum

OCTOBER 7, 2024

Learn how Oliver Stohlmann nurtures the mentor in you, emphasising values like integrity. Discover how you can become a mentor and make a difference in someone's life.

106

106

European Pharmaceutical Review

OCTOBER 7, 2024

New results from a first-of-its-kind study reports that a CAR-T cell therapy provided similar efficacy and safety to relapsed or refractory multiple myeloma patients administered with the treatment in clinical trials. For example, of the 236 patients who received infusions of ciltacabtagene autoleucel (cilta-cel), data shows that 89 percent responded to the treatment.

FDA 105

FDA 105

pharmaphorum

OCTOBER 7, 2024

AstraZeneca pays $100m upfront for rights to an oral lipoprotein(a) drug developed by Chinese biotech CSPC Pharmaceutical.

105

105